Moreover, the findings that AMACR expression was elevated not only in prostate cancer but also in colon [71,72], gastric [73], breast [74], renal, and hepatocellular carcinoma [75] suggest that peroxisomal branched chain fatty acid metabolism may be associated with a broader range of tumors in addition to prostate cancer. This evidence concerns the gene AMACR and prostate carcinoma.